Free Trial
OTCMKTS:IMVIQ

IMV (IMVIQ) Stock Price, News & Analysis

IMV logo

About IMV Stock (OTCMKTS:IMVIQ)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
3,567 shs
Market Capitalization
$2 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

IMV Inc. was a Canadian clinical-stage biotechnology company focused on developing immunotherapies for cancer and other serious diseases. The company’s research was based on its proprietary DPX delivery platform, which was designed to present antigens to the immune system and stimulate targeted T-cell responses.

IMV’s leading product candidate was maveropepimut-S, also known as MVP-S or DPX-Survivac, an investigational cancer immunotherapy developed for conditions including ovarian cancer, bladder cancer and diffuse large B-cell lymphoma. The company also evaluated its platform for additional therapeutic applications, although its programs remained in clinical development and were not approved commercial products.

Founded in Canada and headquartered in Dartmouth, Nova Scotia, IMV conducted clinical development activities through collaborations and research programs in North America and internationally. In 2023, the company sought protection under Canada’s Companies’ Creditors Arrangement Act amid financial difficulties and subsequently ceased or substantially wound down its operations. IMV’s securities traded under the symbol IMVIQ on the OTC market after the company’s financial restructuring and trading-status changes.

AI Generated. May Contain Errors.

Receive IMVIQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IMV and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMVIQ Stock News Headlines

The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.tc pixel
Why virtual pets feel so real now
Level up your IMVU fashion game in 2026
See More Headlines

IMVIQ Stock Analysis - Frequently Asked Questions

Shares of IMVIQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
10/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
OTCMKTS:IMVIQ
CIK
1734768
Fax
N/A
Employees
100
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$330 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.69) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
11,712,000
Free Float
11,673,000
Market Cap
$2 thousand
Optionable
Not Optionable
Beta
0.90
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (OTCMKTS:IMVIQ) was last updated on 10/11/2026 by MarketBeat.com Staff.
From Our Partners